Prime
A Ugandan contact of a patient who tested positive for Ebola is vaccinated with a trial vaccine at the Mulago Guest House (isolation centre) in Kampala on February 3, 2025.
Photo credit: Reuters
Ugandan scientists have begun the first phase of human clinical trials for an experimental vaccine targeting the Bundibugyo strain of Ebola, offering hope of a longer-term defence against a viral disease that has so far spread across three regions of Africa.